New model aims to predict lung cancer treatment outcomes and side effects
NCT ID NCT07243899
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This completed observational study looked at 3,000 people with advanced non-small cell lung cancer who received immunotherapy plus chemotherapy. Researchers built a model using chest CT scans, lung function tests, and immune markers to predict how well the treatment would work and the risk of a serious side effect called pneumonitis. The goal is to help doctors tailor treatment for each patient.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If successful, this could help doctors personalize treatment for advanced lung cancer by better predicting who will benefit and who is at risk for serious side effects.
What could go wrong
This is an observational study, not a treatment trial, so it won't directly improve outcomes. The model may not be accurate enough for routine use.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NSCLC are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
180 Fenglin Road
Shanghai, Shanghai Municipality, 200032, China